| 臺大學術典藏 |
2020-10-22T07:28:05Z |
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
|
Wang T.-S.;Tsen-Fang Tsai; Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-28T02:39:33Z |
Safety and Effectiveness of Hyaluronic Acid Fillers With Lidocaine for Full-Face Treatment in Asian Patients
|
Huang, She-Hung;Tsen-Fang Tsai; Huang, She-Hung; TSEN-FANG TSAI |
| 國立成功大學 |
2017 |
Safety and effectiveness of intravenous thrombolysis for acute ischemic stroke outside the coverage of National Health Insurance in Taiwan
|
Su, Y.-H.;Lin, H.-J.;Chen, Y.-W.;Tseng, M.-C.;Hsieh, Hsieh H.-C.;Chen, Chen C.-H.;Sung, Sung S.-F. |
| 國立成功大學 |
2021 |
Safety and effectiveness of new embolization microspheres SCBRM for intermediate-stage hepatocellular carcinoma: A feasibility study
|
Liu;Yi-Sheng;Lin;Xi-Zhang;Chen;Chiung-Yu;Chiu;Yen-Cheng;Kang;Jui-Wen;Tsai;Hung-Wen;Hung;Hui-Yu;Ho;Chi-Ming;Ou;Ming-Ching |
| 中國醫藥大學 |
2014-10 |
Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn’s Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
|
(Chen-Wang Chang);(Shu-Chen Wei);周仁偉(Jen-Wei Chou);(Tzu-Chi Hsu);(Chiao-Hsiung Chuang);(Ching-Pin Lin);(Wen-Hung Hsu);(Hsu-Heng Yen);(Jen-Kou Lin);(Yi-Jen Fang);(Horng-Yuan Wang);(Hung-Hsin Lin);(Deng Cheng Wu);(Yen Hsuan Ni);(Cheng-Yi Wang);(Jau-Min Wong)* |
| 國立成功大學 |
2000-08 |
Safety and efficacy of Alprostadil Sterile Powder (S. Po.. CAVERJECT (R)) in diabetic patients with erectile dysfunction
|
Tsai, Yuh-Shyan; Lin, Johnny Shinn-Nan; Lin, Yung-Ming |
| 臺大學術典藏 |
2022-03-28T02:45:55Z |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera J.; Kishnani P.S.; Kushlaf H.; Ladha S.; Mozaffar T.; Straub V.; Toscano A.; van der Ploeg A.T.; Berger K.I.; Clemens P.R.; YIN-HSIU CHIEN; Day J.W.; Illarioshkin S.; Roberts M.; Attarian S.; Borges J.L.; Bouhour F.; Choi Y.C.; Erdem-Ozdamar S.; Goker-Alpan O.; Kostera-Pruszczyk A.; Haack K.A.; Hug C.; Huynh-Ba O.; Johnson J.; Thibault N.; Zhou T.; Dimachkie M.M.; Schoser B.; Behin A.; Boentert M.; Carvalho G.; Chahin N.; Charrow J.; Deegan P.; Durmus Tekce H.; Duval F.; Genge A.; Gutmann L.; Henderson R.D.; Hennermann J.B.; Hiwot T.; Hughes D.; Karaa A.; Karam C.; Kautzky-Willer A.; Komaki H.; Laforet P.; Longo N.; Malinova V.; Mar? R.; Maxit C.; Mengel E.; Moggio M.G.; Moln?r M.J.; Mongini T.E.; Nadaj-Pakleza A.; Nascimento Osorio A.; Noury J.-B.; Oliveira A.S.B.; Parman Y.; Pena L.; Remiche G.; Sciacco M.; Shieh P.B.; Smith C.; Stulnig T.; Taithe F.; Tard C.; Tarnopolsky M.; Vorgerd M.; Whitley C.; Young P.; Alonso-P?rez J.; Altemus P.; Aub?-Nathier A.-C.; Avelar J.B.; Bailey C.; Bekircan-Kurt C.E.; Billy J.; Boschi S.; Brown K.E.; Carrera Garcia L.; Chase L.; Cirne H.; Danjoux L.; Davion J.-B.; DeArmey S.; Fedotova E.; Gandolfo E.; Grosz Z.; Guellec D.; Guettsches A.-K.; Guglieri M.; Hatcher E.; Helms S.; Hufgard-Leitner M.; Klyushnikov S.A.; Langton J.; Linkov? L.; Mavroudakis N.; Mazurov? S.; Mori M.; M?ller-Miny L.; Musumeci O.; Nance C.S.; Natera-de Benito D.; Neel R.; Niizawa G.A.; Noll L.; Ortega E.; Pasnoor M.; Pautot V.; Potulska-Chromik A.; Pugliese A.; Questienne C.; Ramos Lopes M.; Reyes-Leiva D.; Riedl M.; Rugiero M.F.; Salort-Campana E.; Sgobbi Souza P.V.; Sole G.; Solera L.; Souto Lopes S.; Specht S.; Statland J.; Swenson A.; Tan C.Y.; Tizon S.; van der Beek N.A.M.E.; van Kooten H.A.; Wencel M.; Wenninger S.; Zagnoli F.; COMET Investigator Group |
| 臺大學術典藏 |
2021-12-14T23:12:28Z |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera, Jordi; Kishnani, Priya S.; Kushlaf, Hani; Ladha, Shafeeq; Mozaffar, Tahseen; Straub, Volker; Toscano, Antonio; van der Ploeg, Ans T.; Berger, Kenneth I.; Clemens, Paula R.; YIN-HSIU CHIEN; Day, John W.; Illarioshkin, Sergey; Roberts, Mark; Attarian, Shahram; Borges, Joao Lindolfo; Bouhour, Francoise; Choi, Young Chul; Erdem-Ozdamar, Sevim; Goker-Alpan, Ozlem; Kostera-Pruszczyk, Anna; Haack, Kristina An; Hug, Christopher; Huynh-Ba, Olivier; Johnson, Judith; Thibault, Nathan; Zhou, Tianyue; Dimachkie, Mazen M.; Schoser, Benedikt; Behin, Anthony; Boentert, Matthias; Carvalho, Gerson; Chahin, Nizar; Charrow, Joel; Deegan, Patrick; Durmus Tekce, Hacer; Duval, Fanny; Genge, Angela; Gutmann, Ludwig; Henderson, Robert D.; Hennermann, Julia B.; Hiwot, Tarekegn; Hughes, Derralynn; Karaa, Amel; Karam, Chafic; Kautzky-Willer, Alexandra; Komaki, Hirofumi; Laforet, Pascal; Longo, Nicola; Malinova, Vera; Maré, Ricardo; Maxit, Clarisa; Mengel, Eugen; Moggio, Maurizio Gualtiero; Molnár, Mária Judit; Mongini, Tiziana Enrica; Nadaj-Pakleza, Aleksandra; Nascimento Osorio, Andres; Noury, Jean Baptiste; Oliveira, Acary Souza Bulle; Parman, Yesim; Pena, Loren; Remiche, Gauthier; Sciacco, Monica; Shieh, Perry B.; Smith, Cheryl; Stulnig, Thomas; Taithe, Frederic; Tard, Céline; Tarnopolsky, Mark; Vorgerd, Matthias; Whitley, Chester; Young, Peter; Alonso-Pérez, Jorge; Altemus, Patricia; Aubé-Nathier, Anne Catherine; Avelar, Jennifer B.; Bailey, Carrie; Bekircan-Kurt, Can Ebru; Billy, Jenny; Boschi, Silvia; Brown, Kathryn E.; Carrera Garcia, Laura; Chase, Lauren; Cirne, Hamilton; Danjoux, Loïc; Davion, Jean Baptiste; DeArmey, Stephanie; Fedotova, Ekaterina; Gandolfo, Eve; Grosz, Zoltan; Guellec, Dewi; Guettsches, Anne Katrin; Guglieri, Michela; Hatcher, Erin; Helms, Sina; Hufgard-Leitner, Miriam; Klyushnikov, Sergey A.; Langton, Jacqui; Linková, Lenka |
| 臺大學術典藏 |
2018-09-10T03:25:34Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang, C.-T. and Chen, Y.-C. and Lin, S.-F. and Shau, W.-Y. and Liu, C.-J. and Sheng, W.-H. and Wang, J.-T. and Chang, S.-C.; WANG-HUEI SHENG |
| 臺大學術典藏 |
2018-09-10T03:23:08Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang, C.-T. and Chen, Y.-C. and Lin, S.-F. and Shau, W.-Y. and Liu, C.-J. and Sheng, W.-H. and Wang, J.-T. and Chang, S.-C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2018-09-10T03:24:39Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang, C.-T. and Chen, Y.-C. and Lin, S.-F. and Shau, W.-Y. and Liu, C.-J. and Sheng, W.-H. and Wang, J.-T. and Chang, S.-C.; CHI-TAI FANG |
| 臺大學術典藏 |
2020-09-29T01:48:24Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.;Yee-Chun Chen;Lin S.-F.;Shau W.-Y.;Liu C.-J.;Sheng W.-H.;Wang J.-T.;Chang S.-C.; Fang C.-T.; YEE-CHUN CHEN; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-26T02:00:29Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.;Chen Y.-C.;Lin S.-F.;Shau W.-Y.;Liu C.-J.;Wang-Huei Sheng;Wang J.-T.;Chang S.-C.; Fang C.-T.; Chen Y.-C.; Lin S.-F.; Shau W.-Y.; Liu C.-J.; WANG-HUEI SHENG; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-04-20T03:46:34Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
CHI-TAI FANG; Chen Y.-C.; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:53:10Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.; YEE-CHUN CHEN; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2020-12-30T02:43:03Z |
Safety and efficacy of cefpirome in comparison with ceftazidime in chinese patients with sepsis due to bacterial infections
|
Fang C.-T.;Chen Y.-C.;Lin S.-F.;Shau W.-Y.;Liu C.-J.;Sheng W.-H.;Wang J.-T.;Shan-Chwen Chang; Fang C.-T.; Chen Y.-C.; Lin S.-F.; Shau W.-Y.; Liu C.-J.; Sheng W.-H.; Wang J.-T.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-06-24T07:16:08Z |
Safety and Efficacy of Ceftazidime-Avibactam in the Treatment of Children ?3 Months to <18 Years with Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
|
Bradley J.S.;Roilides E.;Broadhurst H.;Cheng K.;Li-Min Huang;Mascasullo V.;Newell P.;Stone G.G.;Tawadrous M.;Wajsbrot D.;Yates K.;Gardner A.; Bradley J.S.; Roilides E.; Broadhurst H.; Cheng K.; LI-MIN HUANG; Mascasullo V.; Newell P.; Stone G.G.; Tawadrous M.; Wajsbrot D.; Yates K.; Gardner A. |
| 臺大學術典藏 |
2022-03-28T02:45:56Z |
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
|
Schoser B.; Roberts M.; Byrne B.J.; Sitaraman S.; Jiang H.; Lafor?t P.; Toscano A.; Castelli J.; D?az-Manera J.; Goldman M.; van der Ploeg A.T.; Bratkovic D.; Kuchipudi S.; Mozaffar T.; Kishnani P.S.; Sebok A.; Pestronk A.; Dominovic-Kovacevic A.; Khan A.; Koritnik B.; Tard C.; Lindberg C.; Quinn C.; Eldridge C.; Bodkin C.; Reyes-Leiva D.; Hughes D.; Stefanescu E.; SALORT-CAMPANA E.; Butler E.; Bouhour F.; Kim G.; Konstantinos Papadimas G.; Parenti G.; Bartosik-Psujek H.; Kushlaf H.; Akihiro H.; Lau H.; Pedro H.; Andersen H.; Amartino H.; Shiraishi H.; Kobayashi H.; Tarnev I.; Vengoechea J.; Avelar J.; Shin J.-H.; Cauci J.; Alonso-P?rez J.; Janszky J.; Berthy J.; Cornelia K.; Gutschmidt K.; Claeys K.; Judit Molnar M.; Wencel M.; Tarnopolsky M.; Dimachkie M.; Tchan M.; Freimer M.; Longo N.; Vidal-Fernandez N.; Musumeci O.; Goker-Alpan O.; Deegan P.; Clemens P.R.; Roxburgh R.; Henderson R.; Hopkin R.; Sacconi S.; Fecarotta S.; Attarian S.; Wenninger S.; Dearmey S.; Hiwot T.; Burrow T.; Ruck T.; Sawada T.; Laszlo V.; L?scher W.; YIN-HSIU CHIEN; PROPEL Study Group |
| 國立臺灣大學 |
2012 |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai, Chung-Chih; Sheng, Wang-Huei; Wang, Jann-Tay; Liao, Chun-Hsin; Ho, Mao-Wang; Chen, Chwen-Je; Chen, Der-Li; Chou, Ming-Uen; Lee, Chien-Ming; Lin, Yee-Chun; Pong, Ming-Ye; Chang, Shan-Chwen; 張上淳 |
| 臺大學術典藏 |
2021-02-26T02:00:01Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; WANG-HUEI SHENG; Wang J.-T.; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:50Z |
Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections
|
Lai C.-C.; Sheng W.-H.; JANN-TAY WANG; Liao C.-H.; Ho M.-W.; Chen C.-J.; Chen D.-L.; Chou M.-U.; Lee C.-M.; Lin Y.-C.; Pong M.-Y.; Chang S.-C. |
| 國立成功大學 |
2019 |
Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
|
Wei, L.;Kumada, H.;Perumalswami, Perumalswami P.V.;Tanwandee, Tanwandee T.;Cheng, W.;Heo, J.;Cheng, P.-N.;Hwang, P.;Mu, S.M.;Zhao, X.M.;Asante-Appiah, E.;Caro, L.;Hanna, G.J.;Robertson, M.N.;Haber, B.A.;Talwani, R. |
| 臺大學術典藏 |
2022-05-14T23:35:54Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-05-17T06:03:52Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
NI-CHUNG LEE; YIN-HSIU CHIEN; Wang, Chung Hsing; Wong, Siew Lee; STEVEN SHINN-FORNG PENG; Tsai, Fuu Jen; WUH-LIANG HWU |
| 臺大學術典藏 |
2022-09-06T02:56:09Z |
Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
|
Lee N.-C.; YIN-HSIU CHIEN; Wang C.-H.; Wong S.-L.; Peng S.S.-F.; Tsai F.-J.; Hwu W.-L. |
| 臺大學術典藏 |
2021-01-15T03:46:39Z |
Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic Neoplasm
|
Paik W.H.; Seo D.W.; Dhir V.; HSIU-PO WANG |
| 國立臺灣大學 |
2008 |
Safety and Efficacy of Exenatide in Patients of Asian Descent with Type 2 Diabetes Taking Metformin or Metformin with a Sulfonylurea
|
莊立民; BRODOWS ROBERT; MOHAN VISHWANATHAN; CHUANG, LEE-MING; YOON KUN HO; GAO YAN |
| 臺大學術典藏 |
2018-09-10T18:03:26Z |
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
|
Wu, M.-Y. ; Chen, Y.-C. ; Lin, C.-H. ; Wu, Y.-C. ; Tu, Y.-K. ; Tarng, D.-C.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-10T08:10:10Z |
Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
|
Wu M.-Y.; Chen Y.-C.; Lin C.-H.; Wu Y.-C.; YU-KANG TU; Tarng D.-C. |
| 國立臺灣大學 |
2013 |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai, Chung-Chih; Sheng, Wang-Huei; Wang, Jann-Tay; Cheng, Aristine; Chuang, Yu-Chung; Chen, Yee-Chun; Chang, Shan-Chwen; 張上淳; 陳宜君; 盛望徽; 王振泰; 莊祐中 |
| 臺大學術典藏 |
2018-09-10T09:46:34Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai, Chung-Chih;Sheng, Wang-Huei;Wang, Jann-Tay;Cheng, Aristine;Chuang, Yu-Chung;Chen, Yee-Chun;Chang, Shan-Chwen; Lai, C.-C. and Sheng, W.-H. and Wang, J.-T. and Cheng, A. and Chuang, Y.-C. and Chen, Y.-C. and Chang, S.-C.; 張上淳 ;陳宜君 ;盛望徽 ;王振泰 ;莊祐中; WANG-HUEI SHENG; Lai, Chung-Chih; Sheng, Wang-Huei; ARISTINE CHENG; Wang, Jann-Tay; SHAN-CHWEN CHANG; YEE-CHUN CHEN; Cheng, Aristine; Chuang, Yu-Chung; YU-CHUNG CHUANG; Chen, Yee-Chun; JANN-TAY WANG; Chang, Shan-Chwen |
| 臺大學術典藏 |
2020-09-29T01:47:47Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Sheng W.-H.; Lai C.-C.; Lai C.-C.;Sheng W.-H.;Wang J.-T.;Cheng A.;Chuang Y.-C.;Yee-Chun Chen;Chang S.-C.; Chang S.-C.; Chuang Y.-C.; YEE-CHUN CHEN; Cheng A.; Wang J.-T. |
| 臺大學術典藏 |
2021-02-26T01:59:57Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; WANG-HUEI SHENG; Wang J.-T.; Cheng A.; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:16Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; Wang J.-T.; Cheng A.; Chuang Y.-C.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-08-16T08:36:25Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; Wang J.-T.; ARISTINE CHENG; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2013 |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.;Sheng W.-H.;Wang J.-T.;Cheng A.;Chuang Y.-C.;Chen Y.-C.;Shan-Chwen Chang; Lai C.-C.; Sheng W.-H.; Wang J.-T.; Cheng A.; Chuang Y.-C.; Chen Y.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-05-13T08:04:45Z |
Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
|
Lai C.-C.; Sheng W.-H.; JANN-TAY WANG; Cheng A.; Chuang Y.-C.; Chen Y.-C.; Chang S.-C. |
| 國立臺灣大學 |
2009-12 |
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants
|
Phua, KB; Lim, FS; Lau, YL; Nelson, EA; Huang, LM; Quak, SH; Lee, BW; Teoh, YL; Tang, H; Boudville, I; Oostvogels, LC; Suryakiran, PV; Smolenov, IV; Han, HH; Bock, HL |
| 國立臺灣大學 |
2009 |
Safety and Efficacy of Human Rotavirus Vaccine during the First 2 Years of Life in Asian Infants: Randomised, Double-Blind, Controlled Study
|
黃立民; HUANG, LI-MIN |
| 臺大學術典藏 |
2018-09-10T07:46:48Z |
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
|
Bock, H.L.; Han, H.H.; Smolenov, I.V.; Suryakiran, P.V.; Oostvogels, L.C.; Teoh, Y.L.; Tang, H.; Boudville, I.; Phua, K.B.;Lim, F.S.;Lau, Y.L.;Nelson, E.A.S.;Huang, L.M.;Quak, S.H.;Lee, B.W.;Teoh, Y.L.;Tang, H.;Boudville, I.;Oostvogels, L.C.;Suryakiran, P.V.;Smolenov, I.V.;Han, H.H.;Bock, H.L.Phua, K.B.; Lim, F.S.; Lau, Y.L.; Nelson, E.A.S.; Huang, L.M.; Quak, S.H.; Lee, B.W.; Teoh, Y.L.; Tang, H.; Boudville, I.; Oostvogels, L.C.; Suryakiran, P.V.; Smolenov, I.V.; Han, H.H.; Bock, H.L.黃立民; Phua, K.B.; Lim, F.S.; Lau, Y.L.; Nelson, E.A.S.; Huang, L.M.; Quak, S.H.; Lee, B.W.; Teoh, Y.L.; Tang, H.; Boudville, I.; Oostvogels, L.C.; Suryakiran, P.V.; Smolenov, I.V.; Han, H.H.; Bock, H.L.; 黃立民; LI-MIN HUANG; Phua, K.B.; Lim, F.S.; Lau, Y.L.; Nelson, E.A.S.; Huang, L.M.; Quak, S.H.; Lee, B.W. |
| 臺大學術典藏 |
2021-06-24T07:16:59Z |
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
|
Phua K.B.; Lim F.S.; Lau Y.L.; Nelson E.A.S.; LI-MIN HUANG; Quak S.H.; Lee B.W.; Teoh Y.L.; Tang H.; Boudville I.; Oostvogels L.C.; Suryakiran P.V.; Smolenov I.V.; Han H.H.; Bock H.L. |
| 國立成功大學 |
2023 |
Safety and efficacy of intracoronary artery administration of human bone marrow-derived mesenchymal stem cells in STEMI of Lee-Sung pigs—A preclinical study for supporting the feasibility of the OmniMSC-AMI phase I clinical trial
|
Chen, W.;Hou, C.-H.;Chen, Y.-L.;Shen, H.-H.;Lin, C.-H.;Wu, C.-Y.;Lin, M.-H.;Liao, C.-C.;Huang, J.-J.;Yang, C.-Y.;Li, Y.-C.;Yip, H.-K. |
| 國立臺灣大學 |
2010 |
Safety and Efficacy of Intravenous Colistin (Colistin Methanesulphonate) for Severe Multidrug-Resistant Gram-Negative Bacterial Infections
|
盛望徽; 王振泰; 陳宜君; 張上淳; SHENG, WANG-HUEI; WANG, JANN-TAY; CHEN, YEE-CHUN; CHANG, SHAN-CHWEN |
| 臺大學術典藏 |
2018-09-10T08:12:34Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng, C.-Y. and Sheng, W.-H. and Wang, J.-T. and Chen, Y.-C. and Chang, S.-C.; WANG-HUEI SHENG; SHAN-CHWEN CHANG; YEE-CHUN CHEN; JANN-TAY WANG |
| 臺大學術典藏 |
2020-12-30T02:43:37Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
SHAN-CHWEN CHANG; Chen Y.-C.; Wang J.-T.; Cheng C.-Y.; Sheng W.-H. |
| 臺大學術典藏 |
2021-02-26T02:00:09Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng C.-Y.;Wang-Huei Sheng;Wang J.-T.;Chen Y.-C.;Chang S.-C.; Cheng C.-Y.; WANG-HUEI SHENG; Wang J.-T.; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-05-06T01:52:31Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng C.-Y.; Sheng W.-H.; Wang J.-T.; YEE-CHUN CHEN; Chang S.-C. |
| 臺大學術典藏 |
2020-09-29T01:47:58Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Chang S.-C.; YEE-CHUN CHEN; Wang J.-T.; Sheng W.-H.; Cheng C.-Y. |
| 臺大學術典藏 |
2022-05-13T08:04:59Z |
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
|
Cheng C.-Y.; Sheng W.-H.; JANN-TAY WANG; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2018 |
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: Week 52 results from SPIRIT-P2
|
Genovese M.C.;Combe B.;Kremer J.M.;Tsen-Fang Tsai;Behrens F.;Adams D.H.;Lee C.;Kerr L.;Nash P.; Genovese M.C.; Combe B.; Kremer J.M.; TSEN-FANG TSAI; Behrens F.; Adams D.H.; Lee C.; Kerr L.; Nash P. |
